Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines

Blood Adv. 2022 Sep 13;6(17):5067-5071. doi: 10.1182/bloodadvances.2021006709.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / drug therapy
  • Lymphoma, Large B-Cell, Diffuse* / genetics
  • Lymphoma, Large B-Cell, Diffuse* / pathology